Top Stocks: Ramsay Health Care Limited, Medibank Private Ltd, Cochlear Limited

Ramsay Health Care Limited (ASX:RHC), Medibank Private Ltd (ASX:MPL) and Cochlear Limited (ASX:COH) are all outperforming the market.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Health sector related stocks remain a key go-to for investors and with good reason.

With the first anniversary of the initial public offering (IPO) of Australia's largest listed health insurer Medibank Private Ltd (ASX: MPL) approaching it's a good time to review the performance of not only this stock but also other companies which offer investors exposure to the thematic of increased demand and spending on health related services.

Since IPO in late November, Medibank's shares are up nearly 20% on the $2 issue price for retail investors. Meanwhile, over the same time frame shareholders in Ramsay Health Care Limited (ASX: RHC) have seen their shares rally around 14% while shares in Cochlear Limited (ASX: COH) are up 22%.

In contrast to the positive performances of these three stocks, the S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) has slumped nearly 5% over the same period.

Here are some of the reasons these three stocks have been outperforming…

Medibank: The ex-government owned insurer reported total income growth of 3% and net profit of $285 million, which was well up on the prior year thanks to no impairments or restructuring charges. The group benefited from two sets of premium rises over the past two years which have outstripped claim cost rises.

Ramsay: The global owner and operator of private hospitals has seen a major boost to its revenues and profits thanks to the acquisition of Generale de Sante which positioned the group as the leading hospital operator in France. Revenues soared 50%, while profits jumped 27% and the final dividend was increased by around 19%.

The group also provided guidance for the current financial year of 12% to 14% profit growth.

Cochlear: The leading provider of implantable hearing devices reported a 15% rise in sales and a 56% surge in net profit to $146 million – helped largely by favourable currency movements. Cochlear was also cycling results off of a lower base in the prior period which was affected by a delay in the release of a new product.

Looking forward and for the current financial year the group is forecasting 13% to 20% profit growth.

Motley Fool contributor Tim McArthur has no position in any stocks mentioned. Unless otherwise noted, the author does not have a position in any stocks mentioned by the author in the comments below. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »